Loading...
A Case of De Novo Psoriasis Secondary to Nivolumab in a Patient With Metastatic Renal Cell Carcinoma
Immune-mediated adverse events are commonly seen with immune checkpoint inhibitors like nivolumab. Oncology specialists usually have to screen patients for risk factors for autoimmune diseases, since immune checkpoint inhibitors can potentially exacerbate these events. Some of the immune-mediated si...
Saved in:
| Published in: | Cureus |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Cureus
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8288591/ https://ncbi.nlm.nih.gov/pubmed/34290912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.15703 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|